The main department of described VC is located in the Maisons-alfort. The company was established in Europe in France.
Besides, a startup requires to be at the age of 6-10 years to receive the investment from the fund. Among the most popular portfolio startups of the fund, we may highlight DBV Technologies, Poxel, Millendo Therapeutics. Among the most popular fund investment industries, there are Therapeutics, Pharmaceutical. The fund has no specific favorite in a number of founders of portfolio startups. If startup sums 5+ of the founder, the chance for it to be financed is low. For fund there is a match between the country of its foundation and the country of its the most frequent investments - France.
The usual things for fund are deals in the range of 10 - 50 millions dollars. This InnoBio Fund works on 41 percentage points more the average amount of lead investments comparing to the other organizations. The higher amount of exits for fund were in 2017. The fund is constantly included in less than 2 deals per year. The real fund results show that this VC is 0 percentage points less often commits exit comparing to other companies. The important activity for fund was in 2010.
The usual cause for the fund is to invest in rounds with 4-5 partakers. Despite the InnoBio Fund, startups are often financed by Sofinnova Partners, OUP (Osage University Partners), Frazier Healthcare Partners. The meaningful sponsors for the fund in investment in the same round are Andera Partners, Omnes Capital, Amundi Private Equity Funds. In the next rounds fund is usually obtained by Andera Partners, Kreos Capital, Bpifrance.
Related Funds
Funds with similar focus
Fund Name | Location |
Aviv Growth Partners | Boston, Massachusetts, United States |
Caber Partners | Central, Central Region, Singapore |
CFM Investments | China, Guangdong, Shenzhen |
Curology | California, San Francisco, United States |
Digital Networks | - |
JGE Capital Management | California, San Francisco, United States |
M13 | California, Santa Monica, United States |
Miston | Espoo, Finland, Uusimaa |
Monday Capital | England, London, United Kingdom |
Notable deals
Company | Industry | Round Size | Date | Investors | Location |
AlgoTherapeutix | $23M | 14 Mar 2023 | Suresnes, Ile-de-France, France | ||
07 Jul 2020 | France, Ile-de-France, France | ||||
Pixium Vision | $17M | 25 Nov 2013 | France, Ile-de-France | ||
Poxel | $15M | 18 Dec 2012 | France, Auvergne-Rhône-Alpes | ||
TxCell | $14M | 26 Nov 2012 | France, Provence-Alpes-Côte d'Azur | ||
DBV Technologies | $25M | 05 Jan 2011 | France, Ile-de-France | ||
Poxel | $21M | 08 Jul 2010 | Lyon, Auvergne-Rhône-Alpes, France | ||
Genticel | $17M | 05 Apr 2010 | France, Ile-de-France |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Latest deals
Company | Industry | Round Size | Date | Investors | Location |
AlgoTherapeutix | $23M | 14 Mar 2023 | Suresnes, Ile-de-France, France | ||
07 Jul 2020 | France, Ile-de-France, France | ||||
Pixium Vision | $17M | 25 Nov 2013 | France, Ile-de-France | ||
Poxel | $15M | 18 Dec 2012 | France, Auvergne-Rhône-Alpes | ||
TxCell | $14M | 26 Nov 2012 | France, Provence-Alpes-Côte d'Azur | ||
DBV Technologies | $25M | 05 Jan 2011 | France, Ile-de-France | ||
Poxel | $21M | 08 Jul 2010 | Lyon, Auvergne-Rhône-Alpes, France | ||
Genticel | $17M | 05 Apr 2010 | France, Ile-de-France |